tm
Seeing Is Believing
tm
Seeing Is Believing
Merrimack Pharmaceuticals's activity chart (see below) currently has 7 price targets and 5 ratings on display.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 502.2 days.
Most recent stock forecast was given by from MORGAN STANLEY on 19-Oct-2018. First documented stock forecast 18-Dec-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-Oct-2018
$4
$-11.13 (-73.56%)
7 years 8 months 25 days ago
(19-Oct-2018)
1/1 (100%)
$1.2 (42.86%)
110
Buy Since 27-Oct-2015
$15
$-0.13 (-0.86%)
10 years 8 months 17 days ago
(27-Oct-2015)
1/1 (100%)
$-22.4 (-59.89%)
436
Buy Since 11-Aug-2015
$16
$0.87 (5.75%)
10 years 11 months 3 days ago
(11-Aug-2015)
1/1 (100%)
$-23.03 (-59.01%)
506
Buy Since 15-Jun-2015
$16
$0.87 (5.75%)
11 years 29 days ago
(15-Jun-2015)
1/1 (100%)
$-26.28 (-62.16%)
563
Buy Since 19-Dec-2014
$11
$-4.13 (-27.30%)
11 years 6 months 25 days ago
(19-Dec-2014)
1/1 (100%)
$-31.74 (-74.26%)
896
What is MACK (Merrimack Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MACK (Merrimack Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MACK (Merrimack Pharmaceuticals)?
Which analyst is the currently most bullish on MACK (Merrimack Pharmaceuticals)?
Which analyst is the currently most reserved on MACK (Merrimack Pharmaceuticals)?
